IP Library Granted Patent US 9,410,193
Granted Patent B2
US 9,410,193 · App. 14/450,344 · Granted Aug 9, 2016

DNA amplification and sequencing using DNA molecules generated by random fragmentation

Inventors: Vladimir L. Makarov (Ann Arbor, MI); Irina Sleptsova (Ann Arbor, MI); Emmanuel Kamberov (Ann Arbor, MI); Eric Bruening (Chelsea, MI)
Assignee: Rubicon Genomics, Inc.
C12Q1/6855C12Q1/6844C12Q1/6846C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,410,193
App. No.
14/450,344
Granted
Aug 9, 2016
Kind
B2
Abstract

The present invention is directed to methods to prepare a DNA molecule or a plurality of DNA molecules by random fragmentation. In some embodiments, the present invention regards preparing a template for DNA sequencing by random fragmentation. In specific embodiments, the random fragmentation comprises chemical fragmentation, mechanical fragmentation, or enzymatic fragmentation. In further specific embodiments, a universal sequence is attached to the 3′ end of the DNA fragments, such as by ligation of an adaptor sequence or by homopolymeric tailing with terminal deoxynucleotidyltransferase. In other embodiments, a library is prepared with methods of the present invention.

Claims (19)

1. An in vitro method of incorporating a 3′ OH group onto the 3′ end of a nucleic acid molecule having a 3′ end that lacks an OH group, the method comprising the steps of:

a) obtaining a nucleic acid molecule having a 3′ end that lacks a 3′ OH group; and

b) incorporating a 3′ OH group onto the 3′ end that lacks an OH group by exposing the molecule to a terminal deoxynucleotidyltransferase in the presence of a guanine ribonucleotide, guanine deoxyribonucleotide, or both, thereby generating a conditioned nucleic acid molecule.

2. The method of claim 1 , wherein a guanine homopolymer extension is generated on the non-extendable 3′ end.

3. The method of claim 1 , further comprising generating at least one blunt end on the conditioned nucleic acid molecule.

4. The method of claim 1 , further comprising ligating an adaptor molecule to at least one end of the conditioned nucleic acid molecule.

5. The method of claim 1 , further comprising amplifying the conditioned nucleic acid molecule.

6. The method of claim 1 , wherein the 3′ end that lacks an OH group is the result of heat-induced damage.

7. The method of claim 1 , wherein the 3′ end that lacks an OH group comprises a dideoxy terminus.

8. The method of claim 1 , wherein the 3′ end that lacks an OH group comprises an amino-blocked terminus.

9. The method of claim 1 , wherein the nucleic acid molecule having a 3′ end that lacks a 3′ OH group is a double-stranded DNA.

10. The method of claim 9 , wherein the 3′ end that lacks an OH group is at a nick in the double-stranded DNA.

11. The method of claim 1 , wherein the nucleic acid molecule having a 3′ end that lacks a 3′ OH group is a product of random fragmentation.

12. The method of claim 11 , wherein the random fragmentation comprises mechanical fragmentation, chemical fragmentation, or enzymatic fragmentation.

13. The method of claim 12 , wherein the mechanical fragmentation comprises hydrodynamic shearing, sonication, or nebulization.

14. The method of claim 12 , wherein the chemical fragmentation comprises acid catalytic hydrolysis, alkaline catalytic hydrolysis, hydrolysis by metal ions, hydroxyl radicals, irradiation, or heating.

15. The method of claim 12 , wherein the enzymatic fragmentation comprises digestion with DNase I.

16. The method of claim 1 , wherein the guanine ribonucleotide, guanine deoxynucleotide, or both are labeled.

17. The method of claim 16 , wherein the label comprises a radionuclide, an affinity tag, a hapten, an enzyme, a chromophore, or a fluorophore.

Assignments (2)
MERGER Recorded Sep 19, 2017
From: RUBICON GENOMICS, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 043631/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2016
From: MAKAROV, VLADIMIR L.; SLEPTSOVA, IRINA; KAMBEROV, EMMANUEL; BRUENING, ERIC
To: RUBICON GENOMICS, INC.
Reel/Frame 040518/0022 →
Continuity (4)
Continuation 12697886 · Feb 1, 2010
Continuation 10293048 · Nov 13, 2002
Provisional Application 60338224 · Nov 13, 2001
Related Publication 20150087528A1 · Mar 26, 2015